Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1996
10/03/1996WO1996030512A1 Conditional expression system
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030405A1 Peptides with growth promotion properties
10/03/1996WO1996030385A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996WO1996030377A1 Nitrogenous macrocyclic compounds
10/03/1996WO1996030362A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/03/1996WO1996030358A1 Phenyl derivatives useful as endothelin receptor antagonists
10/03/1996WO1996030353A1 Reversible protease inhibitors
10/03/1996WO1996030350A1 Amidine derivatives
10/03/1996WO1996030343A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030339A1 Pyrrolidinyl hydroxamic acid compounds and their production process
10/03/1996WO1996030333A1 Bicyclic amine derivatives and their use as anti-psychotic agents
10/03/1996WO1996030332A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/03/1996WO1996030055A2 Radiolabeled peptides for diagnosis and therapy
10/03/1996WO1996030048A1 Protein kinase c inhibitors
10/03/1996WO1996030042A2 Methods of treating inflammation and compositions therefor
10/03/1996WO1996030035A1 β-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS
10/03/1996WO1996030031A1 Isolated stromal cells and methods of using the same
10/03/1996WO1996030028A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
10/03/1996WO1996030025A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
10/03/1996WO1996030015A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030014A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030007A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
10/03/1996WO1996030003A1 Medicaments for the selective treatment of tumour tissues
10/03/1996WO1996029999A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
10/03/1996WO1996029987A1 Reduction of adhesions using controlled delivery of active oxygen inhibitors
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2216878A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996CA2216806A1 Insulin mimetic and enhancer assay
10/03/1996CA2216755A1 Peptides with growth promotion properties
10/03/1996CA2216707A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2216564A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216526A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216278A1 Transdermally administrable medicament with ace inhibitors
10/03/1996CA2216151A1 Reversible protease inhibitors
10/03/1996CA2215720A1 .beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
10/03/1996CA2215143A1 Isolated stromal cells and methods of using the same
10/03/1996CA2214988A1 Method of treating inflammation and compositions therefor
10/03/1996CA2214451A1 Conditional expression system
10/02/1996EP0735141A2 Process for preparation of benzo(b)thiophene glucuronides
10/02/1996EP0735038A1 Protein kinase C inhibitors
10/02/1996EP0734730A1 Use of a CGRP antagonist for the treatment of ocular or eyelid pruritis and disesthesies
10/02/1996EP0734729A1 Use of a CGRP antagonist for the treatment of cutaneous erythema of neurogenic origin and so obtained composition
10/02/1996EP0734728A1 Use of a CGRP antagonist for the treatment of lichens and pruritis and composition so obtained
10/02/1996EP0734721A2 Method of incorporating drugs into a polymer component of stents
10/02/1996EP0734448A1 Gene therapy for restenosis using an adenoviral vector
10/02/1996EP0734394A1 Peptide inhibitors of cxc intercrine molecules
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996EP0734384A1 3-substituted 1-arylindole compounds
10/02/1996EP0734379A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
10/02/1996EP0734376A1 Vitamin d amine and amide derivatives
10/02/1996EP0734374A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
10/02/1996EP0734371A1 Novel retinoid conjugate compounds and methods for treating skin aging
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996EP0734261A1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
10/02/1996EP0734259A1 Antipsychotic method
10/02/1996EP0734255A1 Novel potassium channel agonist produced from trichoderma virens
10/02/1996EP0734248A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
10/02/1996EP0653943A4 Targeting somatic gene therapy to joints.
10/02/1996EP0597850B1 Crystalline interleukin-4
10/02/1996EP0487617B1 Synthetic peptides that enhance cell binding
10/02/1996EP0485578B1 Neurotropic growth factors comprising a homeobox peptide
10/02/1996DE19512181A1 Transdermal applizierbares Arzneimittel mit ACE-Hemmern Transdermally administrable drug with ACE inhibitors
10/02/1996CN1132511A Matrix metalloprotease inhibitors
10/02/1996CN1132508A Piperazine derivatives
10/02/1996CN1132205A Novel pharmaceutical product
10/02/1996CN1132204A Novel heterocyclic amides
10/02/1996CN1132202A New benzopyran derivatives, their process of preparation and pharmaceutical compositions which contain them
10/02/1996CN1132072A NK-1 receptor antagonists for treatment of neuronal injury and stroke
10/01/1996US5561163 Treating hearing loss with deprenyl
10/01/1996US5561149 For nasal administration
10/01/1996US5561148 Oxazolidine derivative
10/01/1996US5561146 Modified guanidino and amidino thrombin inhibitors
10/01/1996US5561144 (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
10/01/1996US5561141 MDR reversal agents
10/01/1996US5561130 Azacyclic compounds
10/01/1996US5561119 Glycosylated prodrugs, their method of preparation and their uses
10/01/1996CA2173046A1 Process for preparation of benzo¬b|thiophene glucuronides
10/01/1996CA1338625C Tricyclic compounds
09/1996
09/26/1996WO1996029425A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
09/26/1996WO1996029412A1 Proteinase k resistant surface protein of neisseria meningitidis
09/26/1996WO1996029409A2 Rage tumor rejection antigens
09/26/1996WO1996029404A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6
09/26/1996WO1996029336A1 Chemical compounds
09/26/1996WO1996029328A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents
09/26/1996WO1996029326A1 3-benzylamino-2-phenylpiperidines as neurokinin antagonists
09/26/1996WO1996029317A1 Aromatic compounds useful as tachykinin antagonists
09/26/1996WO1996029315A2 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/26/1996WO1996029313A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
09/26/1996WO1996029309A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS
09/26/1996WO1996029087A1 Methods for reduced renal uptake of antibody fragments
09/26/1996WO1996029080A1 Poly(hydroxy acid)/polymer conjugates for skin applications
09/26/1996WO1996029075A1 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
09/26/1996WO1996029066A1 Prilocaine and hydrofluorocarbon aerosol preparations
09/26/1996WO1996024372A3 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
09/26/1996WO1996023504A3 Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates
09/26/1996WO1996022774A3 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
09/26/1996WO1996021014A3 Production and administration of high titer recombinant retroviruses
09/26/1996CA2215730A1 Human metabotropic glutamate receptor subtype mglur6
1 ... 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 ... 1564